date/time interval
- September 1, 2022 - August 31, 2025
Targeting Fam20c, an obesity-induced kinase, for precision therapeutics of type 2 diabetes
Grant
Overview
awarded by
administered by
sponsor award ID
- 9-22-PDFPM-01
Affiliation
contributor
- Gilani, Ankit Principal Investigator 2022 - 2025